| Title
|
An Overview of Regenerative Medicine Commercialization in
Canada
|
| Speaker
|
Dr. Rahul Sarugaser
Manager, Commercialization
Centre for Commercialization of Regenerative Medicine
|
| Day and Time
|
Tuesday, October 25, 2011, 6:30 p.m. - 8:00 p.m.
** Free with registration. Please register using the information below.
|
| Location |
O'Grady's tap a grill (upstairs)
171 College Street
Toronto, Ontario M5T 1P7
map |
| Organizer |
IEEE EMBS Toronto Section |
| Contact
|
Barry Vuong, E-mail:
Wendy Qiao, E-mail:
|
| Abstract |
CCRM
(ccrm.ca) is a public-private partnership between
industry, academia and the Canadian Centres of Excellence
for Commercialization of Research. Its mission is to create a
global nexus for regenerative medicine commercialization by
unifying dynamic business leadership with high value stem cell
technologies. This overview talk will present the regenerative
medicine commercialization in Canada.
|
Biography |
Rahul is responsible for CCRMÕs business development
activities including, assessment and in-licensing of high-potential
regenerative medicine intellectual property (IP) assets, including
the diligence of IP emerging from member institutions and
managing Industry Consortium relationships. Before joining CCRM,
Rahul was an Investment Manager with the MaRS Investment
Accelerator Fund, a Toronto-based venture capital fund where he
evaluated and executed due diligence on life-science companies
for seed-stage through series-B investment. Prior to that, he
worked in strategic marketing at GE Healthcare's headquarters
in the UK, identifying in-licensing and investment opportunities for
GE's cell therapy and devices portfolio. Rahul has published and
presented in the stem cell field, and is an inventor on two patents
that have been licensed to Tissue Regeneration Therapeutics in
Toronto. Rahul holds a PhD in Biomedical Engineering from the
University of Toronto and an MBA from the University of Oxford.
|
